China Biologic Products (CBPO) Misses Q2 EPS by 1c

China Biologic Products (NASDAQ: CBPO) reported Q2 EPS of $1.35, $0.01 worse than the analyst estimate of $1.36. Revenue for the quarter came in at $89.3 million versus the consensus estimate of $96.47 million.

Guidance:

FY 2017 revenue up 13-15%

For earnings history and earnings-related data on China Biologic Products (CBPO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M